Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 206 entries
Sorted by: Best Match Show Resources per page
Science or graduates: How do firms benefit from the proximity of universities?

discipline specific-education (e.g., chemistry education, biology education, economics education)

Leten B, Landoni P, Van B.
GSID: 5VrCYYTO5usJ
B Leten, P Landoni, B Van Looy - Research Policy, 2014 - Elsevier

… (university departments) and R&D expenditures (economic sectors) can only be matched with … When we replace the sector-specific education and scientific research variables with total … For example, the field of ‘chemistry’ relates to both the chemical and...

Cite
Leten, B., Landoni, P., & Van Looy, B. (2014). Science or graduates: How do firms benefit from the proximity of universities?. Research Policy, 43(8), 1398-1412.
Leten, Bart, Paolo Landoni, and Bart Van Looy. "Science or graduates: How do firms benefit from the proximity of universities?." Research Policy 43.8 (2014): 1398-1412.
Copy Download .nbib Format: MLA
Developing technology in the vicinity of science: do firms benefit? An overview and empirical assessment on the level of Italian provinces

discipline specific-education (e.g., chemistry education, biology education, economics education)

Landoni P, Leten B, Van B.
GSID: hofsrrV5SkoJ
B Leten, P Landoni, B Van Looy - Science and Innovation Policy …, 2011 - elgaronline.com

Since the seminal work of Schumpeter (1934) and Solow (1957), the idea that economic growth relies on the production of new knowledge has gained wide acceptance. Firms are …

Cite
Leten, B., Landoni, P., & Van Looy, B. (2011). Developing technology in the vicinity of science: do firms benefit? An overview and empirical assessment on the level of Italian provinces. Science and Innovation Policy for the New Knowledge Economy.
Leten, Bart, Paolo Landoni, and Bart Van Looy. "Developing technology in the vicinity of science: do firms benefit? An overview and empirical assessment on the level of Italian provinces." Science and Innovation Policy for the New Knowledge Economy (2011).
Copy Download .nbib Format: MLA
Imaging Metal-on-Metal Hip Replacements: the Norwich Experience.

HSS journal : the musculoskeletal journal of Hospital for Special Surgery

Thomas MS, Wimhurst JA, Nolan JF, Toms AP.
PMID: 24039614
HSS J. 2013 Oct;9(3):247-56. doi: 10.1007/s11420-013-9357-5. Epub 2013 Aug 24.

BACKGROUND: Adverse reaction to metal debris is a relatively recently described and often a silent complication of metal-on-metal (MOM) total hip replacements (THR). The Norfolk & Norwich University Hospital has been performing metal artefact reduction (MARS) MRI for 8...

Cite
Thomas MS, Wimhurst JA, Nolan JF, et al. Imaging Metal-on-Metal Hip Replacements: the Norwich Experience. HSS J. 2013;9(3):247-56doi: 10.1007/s11420-013-9357-5.
Thomas, M. S., Wimhurst, J. A., Nolan, J. F., & Toms, A. P. (2013). Imaging Metal-on-Metal Hip Replacements: the Norwich Experience. HSS journal : the musculoskeletal journal of Hospital for Special Surgery, 9(3), 247-56. https://doi.org/10.1007/s11420-013-9357-5
Thomas, Marianna S, et al. "Imaging Metal-on-Metal Hip Replacements: the Norwich Experience." HSS journal : the musculoskeletal journal of Hospital for Special Surgery vol. 9,3 (2013): 247-56. doi: https://doi.org/10.1007/s11420-013-9357-5
Thomas MS, Wimhurst JA, Nolan JF, Toms AP. Imaging Metal-on-Metal Hip Replacements: the Norwich Experience. HSS J. 2013 Oct;9(3):247-56. doi: 10.1007/s11420-013-9357-5. Epub 2013 Aug 24. PMID: 24039614; PMCID: PMC3772162.
Copy Download .nbib Format: NLM
Celecoxib for the prevention of nonmuscle invasive bladder cancer: results from a matched control study.

Therapeutic advances in urology

Pagliarulo V, Ancona P, Martines I, Spadavecchia R, Di Stasi S, Alba S, Cormio L, Fanizza C, Salerno A, Carrieri G, Pagliarulo A.
PMID: 26622316
Ther Adv Urol. 2015 Dec;7(6):303-11. doi: 10.1177/1756287215599695.

OBJECTIVES: New targets and approaches are under investigation for the treatment of nonmuscle invasive bladder cancer (NMIBC). Preclinical data suggest cyclooxygenase-2 (COX-2) as a promising target. Celecoxib, a COX-2 selective inhibitor, inhibits tumor development and enhances survival, both in...

Cite
Pagliarulo V, Ancona P, Martines I, et al. Celecoxib for the prevention of nonmuscle invasive bladder cancer: results from a matched control study. Ther Adv Urol. 2015;7(6):303-11doi: 10.1177/1756287215599695.
Pagliarulo, V., Ancona, P., Martines, I., Spadavecchia, R., Di Stasi, S., Alba, S., Cormio, L., Fanizza, C., Salerno, A., Carrieri, G., & Pagliarulo, A. (2015). Celecoxib for the prevention of nonmuscle invasive bladder cancer: results from a matched control study. Therapeutic advances in urology, 7(6), 303-11. https://doi.org/10.1177/1756287215599695
Pagliarulo, Vincenzo, et al. "Celecoxib for the prevention of nonmuscle invasive bladder cancer: results from a matched control study." Therapeutic advances in urology vol. 7,6 (2015): 303-11. doi: https://doi.org/10.1177/1756287215599695
Pagliarulo V, Ancona P, Martines I, Spadavecchia R, Di Stasi S, Alba S, Cormio L, Fanizza C, Salerno A, Carrieri G, Pagliarulo A. Celecoxib for the prevention of nonmuscle invasive bladder cancer: results from a matched control study. Ther Adv Urol. 2015 Dec;7(6):303-11. doi: 10.1177/1756287215599695. PMID: 26622316; PMCID: PMC4647141.
Copy Download .nbib Format: NLM
Tunable gold catalysts for selective hydrocarbon oxidation under mild conditions.

Nature

Hughes MD, Xu YJ, Jenkins P, McMorn P, Landon P, Enache DI, Carley AF, Attard GA, Hutchings GJ, King F, Stitt EH, Johnston P, Griffin K, Kiely CJ.
PMID: 16237439
Nature. 2005 Oct 20;437(7062):1132-5. doi: 10.1038/nature04190.

Oxidation is an important method for the synthesis of chemical intermediates in the manufacture of high-tonnage commodities, high-value fine chemicals, agrochemicals and pharmaceuticals: but oxidations are often inefficient. The introduction of catalytic systems using oxygen from air is preferred...

Cite
Hughes MD, Xu YJ, Jenkins P, et al. Tunable gold catalysts for selective hydrocarbon oxidation under mild conditions. Nature. 2005;437(7062):1132-5doi: 10.1038/nature04190.
Hughes, M. D., Xu, Y. J., Jenkins, P., McMorn, P., Landon, P., Enache, D. I., Carley, A. F., Attard, G. A., Hutchings, G. J., King, F., Stitt, E. H., Johnston, P., Griffin, K., & Kiely, C. J. (2005). Tunable gold catalysts for selective hydrocarbon oxidation under mild conditions. Nature, 437(7062), 1132-5. https://doi.org/10.1038/nature04190
Hughes, Mathew D, et al. "Tunable gold catalysts for selective hydrocarbon oxidation under mild conditions." Nature vol. 437,7062 (2005): 1132-5. doi: https://doi.org/10.1038/nature04190
Hughes MD, Xu YJ, Jenkins P, McMorn P, Landon P, Enache DI, Carley AF, Attard GA, Hutchings GJ, King F, Stitt EH, Johnston P, Griffin K, Kiely CJ. Tunable gold catalysts for selective hydrocarbon oxidation under mild conditions. Nature. 2005 Oct 20;437(7062):1132-5. doi: 10.1038/nature04190. PMID: 16237439.
Copy Download .nbib Format: NLM
Editorial.

Metabolic syndrome and related disorders

Dandona P.
PMID: 18370670
Metab Syndr Relat Disord. 2004;2(1):1. doi: 10.1089/met.2004.2.1.

No abstract available.

Cite
Dandona P. Editorial. Metab Syndr Relat Disord. 2004;2(1):1doi: 10.1089/met.2004.2.1.
Dandona, P. (2004). Editorial. Metabolic syndrome and related disorders, 2(1), 1. https://doi.org/10.1089/met.2004.2.1
Dandona, Paresh. "Editorial." Metabolic syndrome and related disorders vol. 2,1 (2004): 1. doi: https://doi.org/10.1089/met.2004.2.1
Dandona P. Editorial. Metab Syndr Relat Disord. 2004;2(1):1. doi: 10.1089/met.2004.2.1. PMID: 18370670.
Copy Download .nbib Format: NLM
Brief report: metabolic syndrome and cardiovascular risk factors among the affluent asian indians living in India.

Metabolic syndrome and related disorders

Kasliwal RR, Bansal M, Agrawal V, Dandona P, Mehrotra R, Garg R.
PMID: 18370682
Metab Syndr Relat Disord. 2004;2(3):169-71. doi: 10.1089/met.2004.2.169.

No abstract available.

Cite
Kasliwal RR, Bansal M, Agrawal V, et al. Brief report: metabolic syndrome and cardiovascular risk factors among the affluent asian indians living in India. Metab Syndr Relat Disord. 2004;2(3):169-71doi: 10.1089/met.2004.2.169.
Kasliwal, R. R., Bansal, M., Agrawal, V., Dandona, P., Mehrotra, R., & Garg, R. (2004). Brief report: metabolic syndrome and cardiovascular risk factors among the affluent asian indians living in India. Metabolic syndrome and related disorders, 2(3), 169-71. https://doi.org/10.1089/met.2004.2.169
Kasliwal, Ravi R, et al. "Brief report: metabolic syndrome and cardiovascular risk factors among the affluent asian indians living in India." Metabolic syndrome and related disorders vol. 2,3 (2004): 169-71. doi: https://doi.org/10.1089/met.2004.2.169
Kasliwal RR, Bansal M, Agrawal V, Dandona P, Mehrotra R, Garg R. Brief report: metabolic syndrome and cardiovascular risk factors among the affluent asian indians living in India. Metab Syndr Relat Disord. 2004;2(3):169-71. doi: 10.1089/met.2004.2.169. PMID: 18370682.
Copy Download .nbib Format: NLM
Lipids, carbohydrates, and heart disease.

Metabolic syndrome and related disorders

Aljada A, Mohanty P, Dandona P.
PMID: 18370661
Metab Syndr Relat Disord. 2003 Sep;1(3):185-8. doi: 10.1089/154041903322716651.

No abstract available.

Cite
Aljada A, Mohanty P, Dandona P. Lipids, carbohydrates, and heart disease. Metab Syndr Relat Disord. 2003;1(3):185-8doi: 10.1089/154041903322716651.
Aljada, A., Mohanty, P., & Dandona, P. (2003). Lipids, carbohydrates, and heart disease. Metabolic syndrome and related disorders, 1(3), 185-8. https://doi.org/10.1089/154041903322716651
Aljada, Ahmad, et al. "Lipids, carbohydrates, and heart disease." Metabolic syndrome and related disorders vol. 1,3 (2003): 185-8. doi: https://doi.org/10.1089/154041903322716651
Aljada A, Mohanty P, Dandona P. Lipids, carbohydrates, and heart disease. Metab Syndr Relat Disord. 2003 Sep;1(3):185-8. doi: 10.1089/154041903322716651. PMID: 18370661.
Copy Download .nbib Format: NLM
Rheological behavior and structural interpretation of waxy crude oil gels.

Langmuir : the ACS journal of surfaces and colloids

Visintin RF, Lapasin R, Vignati E, D'Antona P, Lockhart TP.
PMID: 15982026
Langmuir. 2005 Jul 05;21(14):6240-9. doi: 10.1021/la050705k.

A waxy crude oil which gels below a threshold temperature has been investigated under static and dynamic conditions, using a combination of rheological methods, optical microscopy, and DSC. Particular attention is given in this work to the influence of...

Cite
Visintin RF, Lapasin R, Vignati E, et al. Rheological behavior and structural interpretation of waxy crude oil gels. Langmuir. 2005;21(14):6240-9doi: 10.1021/la050705k.
Visintin, R. F., Lapasin, R., Vignati, E., D'Antona, P., & Lockhart, T. P. (2005). Rheological behavior and structural interpretation of waxy crude oil gels. Langmuir : the ACS journal of surfaces and colloids, 21(14), 6240-9. https://doi.org/10.1021/la050705k
Visintin, Ruben F G, et al. "Rheological behavior and structural interpretation of waxy crude oil gels." Langmuir : the ACS journal of surfaces and colloids vol. 21,14 (2005): 6240-9. doi: https://doi.org/10.1021/la050705k
Visintin RF, Lapasin R, Vignati E, D'Antona P, Lockhart TP. Rheological behavior and structural interpretation of waxy crude oil gels. Langmuir. 2005 Jul 05;21(14):6240-9. doi: 10.1021/la050705k. PMID: 15982026.
Copy Download .nbib Format: NLM
Continuing challenge of infectious diseases in India.

Lancet (London, England)

John TJ, Dandona L, Sharma VP, Kakkar M.
PMID: 21227500
Lancet. 2011 Jan 15;377(9761):252-69. doi: 10.1016/S0140-6736(10)61265-2. Epub 2011 Jan 10.

In India, the range and burden of infectious diseases are enormous. The administrative responsibilities of the health system are shared between the central (federal) and state governments. Control of diseases and outbreaks is the responsibility of the central Ministry...

Cite
John TJ, Dandona L, Sharma VP, et al. Continuing challenge of infectious diseases in India. Lancet. 2011;377(9761):252-69doi: 10.1016/S0140-6736(10)61265-2.
John, T. J., Dandona, L., Sharma, V. P., & Kakkar, M. (2011). Continuing challenge of infectious diseases in India. Lancet (London, England), 377(9761), 252-69. https://doi.org/10.1016/S0140-6736(10)61265-2
John, T Jacob, et al. "Continuing challenge of infectious diseases in India." Lancet (London, England) vol. 377,9761 (2011): 252-69. doi: https://doi.org/10.1016/S0140-6736(10)61265-2
John TJ, Dandona L, Sharma VP, Kakkar M. Continuing challenge of infectious diseases in India. Lancet. 2011 Jan 15;377(9761):252-69. doi: 10.1016/S0140-6736(10)61265-2. Epub 2011 Jan 10. PMID: 21227500.
Copy Download .nbib Format: NLM
What do we mean by cataract outcomes?.

Community eye health

Dandona L, Limburg H.
PMID: 17491957
Community Eye Health. 2000;13(35):35-6.

No abstract available.

Cite
Dandona L, Limburg H. What do we mean by cataract outcomes?. Community Eye Health. 2000;13(35):35-6
Dandona, L., & Limburg, H. (2000). What do we mean by cataract outcomes?. Community eye health, 13(35), 35-6.
Dandona, L, and Limburg, H. "What do we mean by cataract outcomes?." Community eye health vol. 13,35 (2000): 35-6.
Dandona L, Limburg H. What do we mean by cataract outcomes?. Community Eye Health. 2000;13(35):35-6. PMID: 17491957; PMCID: PMC1705976.
Copy Download .nbib Format: NLM
Are thiazolidinediones associated with an increased risk of heart failure and cardiovascular death?.

Nature clinical practice. Cardiovascular medicine

Dandona P, Chaudhuri A.
PMID: 18301389
Nat Clin Pract Cardiovasc Med. 2008 May;5(5):244-5. doi: 10.1038/ncpcardio1121. Epub 2008 Feb 26.

No abstract available.

Cite
Dandona P, Chaudhuri A. Are thiazolidinediones associated with an increased risk of heart failure and cardiovascular death?. Nat Clin Pract Cardiovasc Med. 2008;5(5):244-5doi: 10.1038/ncpcardio1121.
Dandona, P., & Chaudhuri, A. (2008). Are thiazolidinediones associated with an increased risk of heart failure and cardiovascular death?. Nature clinical practice. Cardiovascular medicine, 5(5), 244-5. https://doi.org/10.1038/ncpcardio1121
Dandona, Paresh, and Chaudhuri, Ajay. "Are thiazolidinediones associated with an increased risk of heart failure and cardiovascular death?." Nature clinical practice. Cardiovascular medicine vol. 5,5 (2008): 244-5. doi: https://doi.org/10.1038/ncpcardio1121
Dandona P, Chaudhuri A. Are thiazolidinediones associated with an increased risk of heart failure and cardiovascular death?. Nat Clin Pract Cardiovasc Med. 2008 May;5(5):244-5. doi: 10.1038/ncpcardio1121. Epub 2008 Feb 26. PMID: 18301389.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 206 entries